BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26

• Business

  Oculus Innovative Sciences, Inc. Reports Third Quarter FY 2010 Financial Results: 30% Reduction in Operating Expenses and 36% Increase in Product Revenue

  February 5, 2010

   · 

  1 min read
• Business

  Alkermes Reports Third Quarter Fiscal 2010 Financial Results

  February 5, 2010

   · 

  1 min read
• Hard To Treat Diseases Incorporated Update On Various Business Developments Evaluations and Proposals

  February 5, 2010

   · 

  6 min read
• Transition Therapeutics Inc. Announces Participation in 12th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference

  February 5, 2010

   · 

  1 min read
• Business

  Kewaunee Scientific Corporation Announces Expansion of Statesville Operations

  February 5, 2010

   · 

  1 min read
• Business

  Tecan and Enigma Diagnostics Sign Global Manufacturing and Supply Agreement for Point-of-Care Molecular Diagnostics Instruments

  February 5, 2010

   · 

  4 min read
• Deals

  BioMarin Pharmaceutical Inc. to Acquire LEAD Therapeutics, Inc. for $18 Million Up Front and Future Milestone Payments

  February 5, 2010

   · 

  6 min read
• Business

  Kern Bhugra, Cofounder of Tibion Corporation, Resigns

  February 5, 2010

   · 

  1 min read
• Drug Development

  Optimer Pharmaceuticals, Inc. Announces Positive Results From Second Fidaxomicin Phase 3 Study in Patients With Clostridium Difficile Infection

  February 5, 2010

   · 

  8 min read
• Drug Development

  Clinical Trial Delays Hit Lipoxen Revenues

  February 5, 2010

   · 

  1 min read